Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Praxbind Available to Help Stop Pradaxa Bleeding Problems at Hospitals Nationwide March 10, 2016 Irvin Jackson Add Your Comments More than five years after the introduction of the controversial anticoagulant Pradaxa, and following thousands of reports involving uncontrollable bleeding suffered by users, the recently approved reversal agent Praxbind is now available in many hospitals nationwide. In a press release issued March 8, Boehringer Ingelheim announced that Praxbind, a specific reversal agent for Pradaxa, is stocked in more than 2,200 hospitals throughout the United States. In addition, the drug maker has published a Praxbind locator tool on it’s website, which helps identify facilities that have the drug in stock near health care providers and patients. Pradaxa (dabigatran) first hit the market in October 2010, as the first member of a new generation of anticoagulants that have been aggressively marketed as a superior replacement for warfarin, which has been the go-to treatment for prevention of blood clots for decades. However, as more patients were switched to this new drug, a surprising number of serious and often fatal injuries were linked to Pradaxa bleeding problems, where doctors were unable to stop or reverse hemorrhaging or major bleeds. Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Similar problems with uncontrollable bleeding have plagued other members of this new generation of drugs, known as novel oral anticoagulants, which also include the blockbuster medications Xarelto (rivaroxaban) and Eliquis (apixaban). Unlike warfarin, which has a known and effective antidote to reverse the blood thinning effects of the drug in the case of an emergency, Pradaxa and other members of this new class were introduced without a reversal agent. As a result, doctors have often been left helpless in stopping bleeds on Pradaxa, Xarelto and Eliquis, increasing the risk of severe injury or death. In October 2015, the FDA approved Praxbind (idarucizumab) as the first antidote for this new class of novel oral anticoagulants, indicating that it is safe and effective as a reversal agent for Pradaxa. As the antidote becomes more widely available, it is hoped that the number of severe and catastrophic bleeding injuries on Pradaxa will be significantly reduced. Pradaxa Uncontrollable Bleeds Boehringer Ingelheim has faced sharp criticism and a number of product liability lawsuits alleging that they never should have sold Pradaxa without an available reversal agent. Similar Xarelto lawsuits and Eliquis lawsuits have also been filed against the makers of those competing medications, which still do not have antidotes approved by the FDA. In 2014, Boehringer Ingelheim agreed to pay more than $650 million in Pradaxa settlements to resolve thousands of claims brought by individuals throughout the U.S. However, the drug maker has continued to face new Pradaxa lawsuits as injuries and wrongful deaths have continued to occur as a result of uncontrollable bleeding. The widespread availability of Praxbind is expected to stem the number of bleeding injuries and new lawsuits substantially. “Boehringer Ingelheim is proud to have been able to make PRAXBIND, the first specific reversal agent for a NOAC, available, and that we have been able to distribute it broadly nationwide,” Sabine Luik, MD, senior vice president, Medicine & Regulatory Affairs, Boehringer Ingelheim Pharmaceuticals, Inc, said in the press release issued this week by the drug maker. “In the rare event that a patient may need PRAXBIND, it is critical that it is readily available.” Xarelto, Eliquis Reversal Agent Under Consideration In December, Portola Pharmaceuticals submitted a drug approval application to the FDA for a reversal agent that the company says will work on Xarelto and Eliquis bleeding problems as well. Known as Annexa (andexanet alfa), that drug was submitted after phase III clinical trials indicated it could stop most cases of Xarelto and Eliquis bleeding in minutes. There are currently more than 4,000 lawsuits pending over Xarelto bleeding problems and that number is expected to continue to grow rapidly, as the medication has become the most widely used novel oral anticoagulant in the class. In the federal court system, the cases are centralized in the Eastern District of Louisiana as part of an MDL, or multidistrict litigation, where a small group of bellwether trials are expected to begin later this year if Xarelto settlements are not reached to resolve the claims. Tags: Bleeding, Blood Thinners, Boehringer Ingelheim, Coumadin, Eliquis, Pradaxa, Praxbind, Warfarin, Xarelto More Pradaxa Lawsuit Stories Jury Awards $540K in Pradaxa Trial Against Boehringer Ingelheim May 21, 2019 Paragard IUD Lawsuit Dismissed on Summary Judgment February 25, 2019 Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Nurse Assist Lawsuit Alleges Infection Caused by Saline Solution Used To Clean Wounds (Posted: yesterday) A lawsuit filed over recalled Nurse Assist sterile water and saline products indicates the lack of sterility led to infections in leg wounds they were supposed to cleanse. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITMcKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (03/21/2025)SteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023) Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (Posted: 4 days ago) A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis. MORE ABOUT: OZEMPIC LAWSUITOzempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (03/27/2025)Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025) More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: 5 days ago) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)
Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018
Nurse Assist Lawsuit Alleges Infection Caused by Saline Solution Used To Clean Wounds (Posted: yesterday) A lawsuit filed over recalled Nurse Assist sterile water and saline products indicates the lack of sterility led to infections in leg wounds they were supposed to cleanse. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITMcKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (03/21/2025)SteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)
Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (Posted: 4 days ago) A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis. MORE ABOUT: OZEMPIC LAWSUITOzempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (03/27/2025)Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: 5 days ago) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)